BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37798161)

  • 21. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous ablation or minimally invasive partial nephrectomy for cT1a renal masses? A propensity score-matched analysis.
    Bianchi L; Chessa F; Piazza P; Ercolino A; Mottaran A; Recenti D; Serra C; Gaudiano C; Cappelli A; Modestino F; Golfieri R; Bertaccini A; Marcelli E; Porreca A; Celia A; Schiavina R
    Int J Urol; 2022 Mar; 29(3):222-228. PubMed ID: 34894001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thermal Ablation Versus Partial Nephrectomy for cT1 Renal Mass in a Solitary Kidney: A Matched Cohort Comparative Analysis.
    Attawettayanon W; Kazama A; Yasuda Y; Zhang JJH; Shah S; Rathi N; Munoz-Lopez C; Lewis K; Li J; Beksac AT; Campbell RA; Kaouk J; Haber GP; Weight C; Martin C; Campbell SC
    Ann Surg Oncol; 2024 Mar; 31(3):2133-2143. PubMed ID: 38071719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
    J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous radiofrequency ablation is an effective treatment option for small renal masses, comparable to partial nephrectomy.
    Pedraza-Sánchez JP; Chaves-Marcos R; Mazuecos-Quirós J; Bisonó-Castillo ÁL; Osmán-García I; Gutiérrez-Marín CM; Medina López RA; Juárez Soto Á
    Eur Radiol; 2023 Nov; 33(11):7371-7379. PubMed ID: 37280356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous Microwave Ablation Versus Cryoablation in the Treatment of T1a Renal Tumors.
    De Cobelli F; Papa M; Panzeri M; Colombo M; Steidler S; Ambrosi A; Cao R; Gusmini S; Marra P; Capitanio U; Bertini R; Venturini M; Losa A; Gaboardi F; Montorsi F; Cardone G
    Cardiovasc Intervent Radiol; 2020 Jan; 43(1):76-83. PubMed ID: 31451888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microwave treatment of renal cell carcinoma adjacent to renal sinus.
    Gao Y; Liang P; Yu X; Yu J; Cheng Z; Han Z; Duan S; Huang H
    Eur J Radiol; 2016 Nov; 85(11):2083-2089. PubMed ID: 27776662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous Microwave Ablation versus Cryoablation for Small Renal Masses (≤4 cm): 12-Year Experience at a Single Center.
    Sun G; Eisenbrey JR; Smolock AR; Lallas CD; Anton KF; Adamo RD; Shaw CM
    J Vasc Interv Radiol; 2024 Jun; 35(6):865-873. PubMed ID: 38360294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous cryoablation versus partial nephrectomy for cT1b renal tumors: An inverse probability weight analysis.
    Aikawa K; Yanagisawa T; Fukuokaya W; Shimizu K; Miyajima K; Nakazono M; Iwatani K; Matsukawa A; Obayashi K; Kimura S; Tsuzuki S; Sasaki H; Abe H; Sadaoka S; Miki J; Kimura T
    Urol Oncol; 2023 Mar; 41(3):150.e11-150.e19. PubMed ID: 36604229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
    Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Safety and efficacy of laparoscopic microwave ablation combined with partial nephrectomy for renal tumors: initial experience].
    Hong BA; Du X; Ji YP; Zhao Q; Wang S; Liu J; Cao YD; Yang X; Du P; Yang Y; Zhang N
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3794-3798. PubMed ID: 34895419
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma.
    Larcher A; Meskawi M; Valdivieso R; Boehm K; Trudeau V; Tian Z; Fossati N; Dell'Oglio P; Lughezzani G; Buffi N; Sun M; Karakiewicz P
    World J Urol; 2016 Mar; 34(3):383-9. PubMed ID: 26047653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence after radical and partial nephrectomy in high complex renal tumor using propensity score matched analysis.
    Kim H; Kim JK; Ye C; Choi JH; Lee H; Oh JJ; Lee S; Hong SK; Byun SS
    Sci Rep; 2021 Feb; 11(1):2919. PubMed ID: 33536492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR.
    Reix B; Bernhard JC; Patard JJ; Bigot P; Villers A; Suer E; Vuong NS; Verhoest G; Alimi Q; Beauval JB; Benoit T; Nouhaud FX; Lenormand C; Hamidi N; Cai J; Eto M; Larre S; El Bakhri A; Ploussard G; Hung A; Koutlidis N; Schneider A; Carrouget J; Droupy S; Marchal S; Doerfler A; Seddik S; Matsugasumi T; Orsoni X; Descazeaud A; Pfister C; Bensalah K; Soulie M; Gill I; Flamand V;
    Prog Urol; 2018 Mar; 28(3):146-155. PubMed ID: 29331568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer.
    Larcher A; Sun M; Dell'Oglio P; Trudeau V; Boehm K; Schiffmann J; Tian Z; Fossati N; Capitanio U; Briganti A; Montorsi F; Karakiewicz P
    Eur J Surg Oncol; 2017 Apr; 43(4):815-822. PubMed ID: 27692535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microwave ablation of the T1a small renal mass: expanding beyond 3 cm.
    Qiu J; Ballantyne C; Yeaman C; Lange M; Morgan J; Mershon JP; Richie I; DeNovio A; Clements MB; Krupski TL; Schenkman N; Lobo JM
    Abdom Radiol (NY); 2023 Aug; 48(8):2695-2704. PubMed ID: 37212853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis.
    Yanagisawa T; Mori K; Kawada T; Motlagh RS; Mostafaei H; Quhal F; Laukhtina E; Rajwa P; Aydh A; König F; Pallauf M; Pradere B; Miki J; Kimura T; Egawa S; Shariat SF
    Urol Oncol; 2022 Jul; 40(7):315-330. PubMed ID: 35562311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.